Beam Therapeutics (BEAM)'s 30-day implied volatility (IV30) was 58.5% at the close on November 13, 2026, up from 47.1% the day before, against a 52-week range of 41.8% to 104.1%. Its 20-day historical volatility was 69.0%.
Data as of November 13, 2026.